CVS Group plc (CVSG.L)
Diss, GB
CVS Group plc, established in 1999 and based in Diss, United Kingdom, is a comprehensive animal care provider with diverse operations. The company's activities are broadly categorized into four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail. It manages a large network of animal veterinary clinics and complementary diagnostic laboratories. CVS Group also offers pet cremation services, including the disposal of clinical waste for veterinary practices, and provides pet burial grounds. Furthermore, the company operates Animed Direct, an e-commerce platform that functions as an online pharmacy and retail outlet, distributing both prescription and over-the-counter animal medications, premium pet nutrition, and various other pet care essentials. Additional services include the supply of veterinary instrumentation and referral services. Currently, CVS Group's portfolio comprises 506 veterinary practices, 3 laboratories, 7 crematoria, and a dedicated online pharmacy.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.81% | +1.71% | +8.12% | -5.80% | +2.21% | -2.57% | +0.89% | -40.65% | -42.75% | +54.92% | +447.48% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 6 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Personal Products & Services: +6.6%+4.0% Q4'25: +8.2% (vs Q4'23)
-
EPS growth Personal Products & Services: +19.6%+212.1% ★ Q4'25: -45.0% (vs Q4'23)
-
FCF margin FCF growth · Personal Products & Services: +11.7%+8.1% ★ Q4'25: +7.3% (vs Q4'23)
-
EBIT margin Personal Products & Services: +10.5%+7.4% Q4'25: +9.8% (vs Q4'23)
-
ROIC Personal Products & Services: +6.9%+5.6% Q4'25: +13.0% (vs Q4'23)
-
Share dilution Personal Products & Services: +0.0%+0.1% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Personal Products & Services: 0.59×2.18× Q4'25: 1.32× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2008 actual |
Jun 2009 actual |
Jun 2010 actual |
Jun 2011 actual |
Jun 2012 actual |
Jun 2013 actual |
Jun 2014 actual |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 7 Rev. Ana. 7 EPS Ana. |
Jun 2027 8 Rev. Ana. 7 EPS Ana. |
Jun 2028 4 Rev. Ana. 1 EPS Ana. |
Jun 2029 2 Rev. Ana. 1 EPS Ana. |
Jun 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
62.15M
est: 64.66M (-3.9%)
|
76.61M
est: 77.64M (-1.3%)
|
85.53M
est: 87.06M (-1.8%)
|
101.49M
est: 102.11M (-0.6%)
|
108.75M
est: 109.82M (-1.0%)
|
120.10M
est: 121.24M (-0.9%)
|
142.90M
est: 143.55M (-0.5%)
|
167.30M
est: 166.73M (+0.3%)
|
218.10M
est: 216.44M (+0.8%)
|
271.80M
est: 270.46M (+0.5%)
|
327.30M
est: 325.87M (+0.4%)
|
406.50M
est: 406.50M (+0.0%)
|
427.80M
est: 414.78M (+3.1%)
|
510.10M
est: 502.34M (+1.5%)
|
554.20M
est: 556.52M (-0.4%)
|
588.90M
est: 606.20M (-2.9%)
|
647.30M
est: 663.42M (-2.4%)
|
673.20M
est: 673.20M (+0.0%)
|
714.00M
709.96M – 716.85M
+6.1% YoY
|
749.46M
738.02M – 754.72M
+5.0% YoY
|
786.35M
785.57M – 787.13M
+4.9% YoY
|
825.87M
817.14M – 830.45M
+5.0% YoY
|
833.40M
824.59M – 838.02M
+0.9% YoY
|
| EBITDA |
6.68M
est: 11.32M (-41.0%)
|
12.39M
est: 1.52M (+712.7%)
|
12.16M
est: 8.07M (+50.6%)
|
13.78M
est: 9.73M (+41.6%)
|
13.25M
est: 10.47M (+26.5%)
|
15.40M
est: 11.45M (+34.5%)
|
17.60M
est: 15.39M (+14.3%)
|
21.80M
est: 17.86M (+22.1%)
|
30.00M
est: 24.92M (+20.4%)
|
39.10M
est: 31.63M (+23.6%)
|
44.10M
est: 40.53M (+8.8%)
|
46.50M
est: 45.99M (+1.1%)
|
63.90M
est: 40.02M (+59.7%)
|
88.20M
est: 52.99M (+66.4%)
|
90.40M
est: 55.46M (+63.0%)
|
118.80M
est: 59.72M (+98.9%)
|
108.40M
est: 116.09M (-6.6%)
|
114.30M
est: 117.81M (-3.0%)
|
124.95M
124.24M – 125.45M
+6.1% YoY
|
131.16M
129.15M – 132.08M
+5.0% YoY
|
137.61M
137.48M – 137.75M
+4.9% YoY
|
144.53M
143.00M – 145.33M
+5.0% YoY
|
145.85M
144.30M – 146.66M
+0.9% YoY
|
| EBIT |
2.70M
est: 5.48M (-50.7%)
|
6.93M
est: 4.20M (+64.9%)
|
5.77M
est: 7.88M (-26.8%)
|
6.08M
est: 6.69M (-9.1%)
|
5.29M
est: 6.85M (-22.8%)
|
6.70M
est: 5.74M (+16.7%)
|
7.40M
est: 7.93M (-6.7%)
|
9.60M
est: 8.81M (+9.0%)
|
11.80M
est: 12.72M (-7.2%)
|
16.80M
est: 14.75M (+13.9%)
|
17.30M
est: 20.68M (-16.4%)
|
15.10M
est: 22.06M (-31.6%)
|
17.50M
est: 15.93M (+9.9%)
|
40.10M
est: 20.55M (+95.1%)
|
42.40M
est: 21.51M (+97.1%)
|
68.40M
est: 23.16M (+195.3%)
|
49.90M
est: 56.23M (-11.3%)
|
49.80M
est: 57.07M (-12.7%)
|
60.52M
60.18M – 60.77M
+6.1% YoY
|
63.53M
62.56M – 63.98M
+5.0% YoY
|
66.66M
66.59M – 66.72M
+4.9% YoY
|
70.01M
69.27M – 70.40M
+5.0% YoY
|
70.65M
69.90M – 71.04M
+0.9% YoY
|
| Net Income |
-339.0K
est: 6.55M (-105.2%)
|
3.04M
est: -720.4K (+521.7%)
|
3.06M
est: 3.38M (-9.5%)
|
3.49M
est: 3.64M (-4.1%)
|
2.89M
est: 3.75M (-23.0%)
|
4.00M
est: 3.20M (+24.9%)
|
4.80M
est: 4.74M (+1.3%)
|
6.80M
est: 5.64M (+20.6%)
|
7.00M
est: 8.83M (-20.7%)
|
11.50M
est: 8.75M (+31.4%)
|
10.70M
est: 13.83M (-22.6%)
|
8.20M
est: 13.34M (-38.5%)
|
5.70M
est: 8.37M (-31.9%)
|
19.30M
est: 6.33M (+204.8%)
|
25.70M
est: 6.63M (+287.8%)
|
41.90M
est: 41.90M (+0.0%)
|
6.20M
est: 64.80M (-90.4%)
|
19.30M
est: 59.22M (-67.4%)
|
61.95M
60.31M – 63.59M
+4.6% YoY
|
67.79M
65.47M – 70.11M
+9.4% YoY
|
74.90M
74.11M – 75.69M
+10.5% YoY
|
82.13M
81.00M – 82.72M
+9.7% YoY
|
55.40M
54.64M – 55.80M
-32.5% YoY
|
| SGA |
18.50M
est: 21.73M (-14.8%)
|
23.94M
est: 24.37M (-1.8%)
|
25.61M
est: 26.91M (-4.8%)
|
30.18M
est: 33.66M (-10.3%)
|
32.38M
est: 32.45M (-0.2%)
|
35.20M
est: 35.77M (-1.6%)
|
39.10M
est: 41.68M (-6.2%)
|
69.30M
est: 45.94M (+50.9%)
|
94.50M
est: 89.94M (+5.1%)
|
107.30M
est: 101.00M (+6.2%)
|
133.90M
est: 109.79M (+22.0%)
|
153.30M
est: 143.97M (+6.5%)
|
151.60M
est: 133.83M (+13.3%)
|
181.80M
est: 143.76M (+26.5%)
|
196.30M
est: 150.44M (+30.5%)
|
200.00M
est: 162.00M (+23.5%)
|
227.10M
est: 222.92M (+1.9%)
|
187.90M
est: 226.22M (-16.9%)
|
239.93M
238.57M – 240.89M
+6.1% YoY
|
251.85M
248.00M – 253.61M
+5.0% YoY
|
264.24M
263.98M – 264.50M
+4.9% YoY
|
277.52M
274.59M – 279.06M
+5.0% YoY
|
280.05M
277.09M – 281.61M
+0.9% YoY
|
| EPS |
-0.01
est: 0.09 (-107.2%)
|
0.06
est: 0.13 (-53.5%)
|
0.06
est: 0.12 (-54.4%)
|
0.06
est: 0.13 (-53.7%)
|
0.05
est: 0.15 (-65.2%)
|
0.07
est: 0.16 (-56.5%)
|
0.08
est: 0.19 (-57.4%)
|
0.12
est: 0.24 (-49.5%)
|
0.12
est: 0.32 (-63.0%)
|
0.19
est: 0.42 (-55.0%)
|
0.16
est: 0.45 (-64.8%)
|
0.12
est: 0.47 (-74.4%)
|
0.08
est: 0.39 (-79.1%)
|
0.27
est: 0.69 (-61.1%)
|
0.36
est: 0.83 (-56.6%)
|
0.59
est: 0.92 (-35.5%)
|
0.09
est: 0.90 (-90.4%)
|
0.27
est: 0.83 (-67.4%)
|
0.86
0.84 – 0.89
+4.3% YoY
|
0.95
0.91 – 0.98
+9.9% YoY
|
1.05
1.03 – 1.05
+10.3% YoY
|
1.14
1.13 – 1.15
+9.3% YoY
|
0.77
0.76 – 0.78
-32.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 3/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-28 | C+ | 2/5 | 3/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-27 | C+ | 2/5 | 3/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-26 | C+ | 2/5 | 3/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | C+ | 2/5 | 3/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-21 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-20 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-18 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-15 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-14 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-13 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-12 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-05 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-01 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | B- | 2/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Amundi Prime UK Mid & Small Cap UCITS ETF DR - GBP (D) PRUK.L | 0.48% | 2.06M | 0.05% |
| 2 | Vanguard FTSE 250 UCITS ETF (GBP) Distributing VMID.DE | 0.29% | 7.76M | 0.10% |
| 3 | Vanguard FTSE 250 UCITS ETF VMIG.MI | 0.29% | 7.76M | 0.10% |
| 4 | HSBC FTSE 250 UCITS ETF HMCX.L | 0.29% | 194.3K | 0.09% |
| 5 | iShares FTSE 250 UCITS ETF MIDD.L | 0.29% | 2.43M | 0.40% |
| 6 | Invesco FTSE 250 UCITS ETF S250.L | 0.29% | 102.0K | 0.12% |
| 7 | Xtrackers FTSE 250 UCITS ETF 1D XMCX.L | 0.28% | 107.1K | 0.15% |
| 8 | iShares MSCI UK Small Cap UCITS ETF CUKS.L | 0.25% | 318.5K | 0.58% |
| 9 | iShares MSCI United Kingdom Small-Cap ETF EWUS | 0.25% | 100.5K | 0.59% |
| 10 | UBS MSCI United Kingdom IMI Socially Responsible UCITS ETF GBP dis UKSR.L | 0.09% | 918.6K | 0.23% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Richard William Mark Fairman | Chief Executive Officer & Director | 721.0K | male |
| Robin Jay Alfonso | Chief Financial Officer & Director | 494.0K | male |
| Paul Higgs | Chief Veterinary Officer & Director | 393.0K | male |
| Gordon Palmer | Head of IT | — | male |
| Helen Finney | Chief People Officer | — | female |
| James Cahill | MVB - Managing Director of CVS International | — | — |
| Charlotte Page | Group Financial Controller & Head of Investor Relations | — | — |
| Scott Morrison | Group General Counsel & Company Secretary | — | male |
| Claire Slater | Chief Operating Officer | — | female |
| Elizabeth McLennan-Green | Small Animal Veterinary Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CVSG.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
